Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients.

MLA

Jain, Sarika, et al. “Incremental Increase in VEGFR1⁺ Hematopoietic Progenitor Cells and VEGFR2⁺ Endothelial Progenitor Cells Predicts Relapse and Lack of Tumor Response in Breast Cancer Patients.” Breast Cancer Research and Treatment, vol. 132, no. 1, Feb. 2012, pp. 235–42. EBSCOhost, https://doi.org/10.1007/s10549-011-1906-3.

APA

Jain, S., Ward, M. M., O’Loughlin, J., Boeck, M., Wiener, N., Chuang, E., Cigler, T., Moore, A., Donovan, D., Lam, C., Cobham, M. V., Schneider, S., Christos, P., Baergen, R. N., Swistel, A., Lane, M. E., Mittal, V., Rafii, S., & Vahdat, L. T. (2012). Incremental increase in VEGFR1⁺ hematopoietic progenitor cells and VEGFR2⁺ endothelial progenitor cells predicts relapse and lack of tumor response in breast cancer patients. Breast Cancer Research and Treatment, 132(1), 235–242. https://doi.org/10.1007/s10549-011-1906-3

Chicago

Jain, Sarika, Maureen M Ward, Jennifer O’Loughlin, Marissa Boeck, Naomi Wiener, Ellen Chuang, Tessa Cigler, et al. 2012. “Incremental Increase in VEGFR1⁺ Hematopoietic Progenitor Cells and VEGFR2⁺ Endothelial Progenitor Cells Predicts Relapse and Lack of Tumor Response in Breast Cancer Patients.” Breast Cancer Research and Treatment 132 (1): 235–42. doi:10.1007/s10549-011-1906-3.